Large-scale testing (Phase 3)Not Yet RecruitingNCT03176186
What this trial is testing
Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest
Who this might be right for
Post-Cardiac Arrest Syndrome
Invero Pharma, Inc. 1,436